Home » Delcath Faces Investor Ire Following Negative FDA Panel Vote
Delcath Faces Investor Ire Following Negative FDA Panel Vote
Delcath is being sued by investors after a negative FDA vote.
Qmed
Qmed
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May